Imaging Diagnostic Systems, Inc. (IDSI) is a medical technology company located in Plantation, Florida, engaged primarily in the research, development, and marketing of a non-invasive breast imaging system. IDSI is a pioneer in the field of medical optical imaging and has made major strides in the detection of breast abnormalities. Since the Company's inception in early 1994, IDSI has developed a revolutionary breast imaging device, named Computed Tomography Laser Breast Imaging (CTLM®) that utilizes state-of-the-art laser technology and proprietary algorithms to create three dimensional cross sectional images of the breast without the use of x-rays and compression.

Recognizing that a non-invasive painless breast imaging system would be a benefit to the consumer and the medical industry, IDSI placed its primary focus in an area of a enormous concern: breast cancer. With over 1.3 million biopsies preformed each year and 80% of those resulting in negative findings, a need for a breast imaging system that was not limited by age, density, or size was evident.

Imaging Diagnostic Systems, Inc. has entered the final stages of the FDA Pre-Market approval process for its CTLM® patented breast imaging system. The company has received CE Marking, CMDCAS (Canada), Canadian License, UL listing, ISO ISO 9001:2000 ISO 13485:2003 certification, China SFDA and FDA export certification, enabling sales in international markets.

IDSI's stock is traded on the Over the Counter Bulletin Board (OTC: BB) under the ticker symbol IMDS.

Shareholders Letter - 2008